| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |